JP2019517262A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019517262A5 JP2019517262A5 JP2018563152A JP2018563152A JP2019517262A5 JP 2019517262 A5 JP2019517262 A5 JP 2019517262A5 JP 2018563152 A JP2018563152 A JP 2018563152A JP 2018563152 A JP2018563152 A JP 2018563152A JP 2019517262 A5 JP2019517262 A5 JP 2019517262A5
- Authority
- JP
- Japan
- Prior art keywords
- nucleic acid
- pharmaceutical composition
- seq
- aare
- nucleic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108020004707 nucleic acids Proteins 0.000 claims 23
- 102000039446 nucleic acids Human genes 0.000 claims 23
- 150000007523 nucleic acids Chemical class 0.000 claims 23
- 239000008194 pharmaceutical composition Substances 0.000 claims 6
- 101710163270 Nuclease Proteins 0.000 claims 5
- 108091033319 polynucleotide Proteins 0.000 claims 4
- 102000040430 polynucleotide Human genes 0.000 claims 4
- 239000002157 polynucleotide Substances 0.000 claims 4
- 230000001105 regulatory effect Effects 0.000 claims 4
- 239000002245 particle Substances 0.000 claims 3
- 108091027981 Response element Proteins 0.000 claims 2
- 239000013543 active substance Substances 0.000 claims 2
- 150000001413 amino acids Chemical class 0.000 claims 2
- 108091033409 CRISPR Proteins 0.000 claims 1
- 206010064571 Gene mutation Diseases 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 claims 1
- 230000002950 deficient Effects 0.000 claims 1
- 230000037213 diet Effects 0.000 claims 1
- 235000005911 diet Nutrition 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 230000006806 disease prevention Effects 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 239000003797 essential amino acid Substances 0.000 claims 1
- 235000020776 essential amino acid Nutrition 0.000 claims 1
- 239000003446 ligand Substances 0.000 claims 1
- 239000012528 membrane Substances 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022110001A JP2022133441A (ja) | 2016-06-03 | 2022-07-07 | Ｃａｓ９ヌクレアーゼをコードする核酸の食餌コントロール発現及びその使用 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP16172964.5 | 2016-06-03 | ||
| EP16172964 | 2016-06-03 | ||
| PCT/EP2017/063549 WO2017207797A1 (en) | 2016-06-03 | 2017-06-02 | Diet controlled expression of a nucleic acid encoding cas9 nuclease and uses thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022110001A Division JP2022133441A (ja) | 2016-06-03 | 2022-07-07 | Ｃａｓ９ヌクレアーゼをコードする核酸の食餌コントロール発現及びその使用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019517262A JP2019517262A (ja) | 2019-06-24 |
| JP2019517262A5 true JP2019517262A5 (enExample) | 2020-07-02 |
| JP7436145B2 JP7436145B2 (ja) | 2024-02-21 |
Family
ID=56148119
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018563152A Active JP7436145B2 (ja) | 2016-06-03 | 2017-06-02 | Ｃａｓ９ヌクレアーゼをコードする核酸の食餌コントロール発現及びその使用 |
| JP2022110001A Pending JP2022133441A (ja) | 2016-06-03 | 2022-07-07 | Ｃａｓ９ヌクレアーゼをコードする核酸の食餌コントロール発現及びその使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022110001A Pending JP2022133441A (ja) | 2016-06-03 | 2022-07-07 | Ｃａｓ９ヌクレアーゼをコードする核酸の食餌コントロール発現及びその使用 |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US20190185832A1 (enExample) |
| JP (2) | JP7436145B2 (enExample) |
| KR (1) | KR102317622B1 (enExample) |
| CN (2) | CN109906271A (enExample) |
| AU (1) | AU2017275769B2 (enExample) |
| BR (1) | BR112018074930A2 (enExample) |
| CA (1) | CA3025591A1 (enExample) |
| IL (1) | IL263291B2 (enExample) |
| RU (1) | RU2771383C2 (enExample) |
| SG (1) | SG11201810772XA (enExample) |
| WO (1) | WO2017207797A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113227152A (zh) * | 2018-08-01 | 2021-08-06 | 科罗拉多大学评议会法人团体 | 用于大分子递送和基因组修饰的可编程设计因子治疗性促融合分泌性g型核外颗粒体囊泡 |
| CN112442528B (zh) * | 2019-08-30 | 2022-08-12 | 深圳华大基因股份有限公司 | Loxhd1基因突变体及其应用 |
| CN114058689B (zh) * | 2020-07-30 | 2024-08-20 | 南京市妇幼保健院 | 一种基因突变检测试剂盒及其应用 |
| US20260000762A1 (en) * | 2022-07-05 | 2026-01-01 | Nutritheragene | Controlled expression of a transgene in human t or nk cells for use in cellular immunotherapy |
| WO2024100176A1 (en) * | 2022-11-10 | 2024-05-16 | Nutritheragene | Controlled gene therapy of ocular diseases |
| CN116732043B (zh) * | 2023-08-10 | 2023-10-17 | 四川省医学科学院·四川省人民医院 | 一种突变基因及其白内障筛查的用途与白内障筛查试剂盒 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2982277B1 (fr) | 2011-11-08 | 2015-08-21 | Agronomique Inst Nat Rech | Cassette d'expression inductible et ses utilisations |
| EP3135765A1 (en) * | 2012-12-06 | 2017-03-01 | Sigma-Aldrich Co. LLC | Crispr-based genome modification and regulation |
| US20150098954A1 (en) * | 2013-10-08 | 2015-04-09 | Elwha Llc | Compositions and Methods Related to CRISPR Targeting |
| RU2016128077A (ru) | 2013-12-12 | 2018-12-06 | Те Брод Инститьют Инк. | Доставка, применение и применения в терапии систем и композиций crispr-cas для лечения обусловленных hbv и вирусных заболеваний и нарушений |
| CN111206032B (zh) | 2013-12-12 | 2024-07-19 | 布罗德研究所有限公司 | 用于基因组编辑的crispr-cas系统和组合物的递送、用途和治疗应用 |
-
2017
- 2017-06-02 RU RU2018142174A patent/RU2771383C2/ru active
- 2017-06-02 KR KR1020197000200A patent/KR102317622B1/ko active Active
- 2017-06-02 WO PCT/EP2017/063549 patent/WO2017207797A1/en not_active Ceased
- 2017-06-02 JP JP2018563152A patent/JP7436145B2/ja active Active
- 2017-06-02 SG SG11201810772XA patent/SG11201810772XA/en unknown
- 2017-06-02 CN CN201780045274.4A patent/CN109906271A/zh active Pending
- 2017-06-02 US US16/304,988 patent/US20190185832A1/en not_active Abandoned
- 2017-06-02 BR BR112018074930-3A patent/BR112018074930A2/pt not_active Application Discontinuation
- 2017-06-02 CA CA3025591A patent/CA3025591A1/en active Pending
- 2017-06-02 CN CN202211117939.7A patent/CN116064534A/zh active Pending
- 2017-06-02 AU AU2017275769A patent/AU2017275769B2/en active Active
-
2018
- 2018-11-26 IL IL263291A patent/IL263291B2/en unknown
-
2022
- 2022-07-07 JP JP2022110001A patent/JP2022133441A/ja active Pending
-
2023
- 2023-01-12 US US18/153,490 patent/US20230313161A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018520997A5 (enExample) | ||
| RU2018142174A (ru) | Контролируемая пищевым рационом экспрессия нуклеиновой кислоты, кодирующей нуклеазу cas9, и ее применения | |
| JP2016538885A5 (enExample) | ||
| JP2016501532A5 (enExample) | ||
| JP2008541759A5 (enExample) | ||
| JP2015510393A5 (enExample) | ||
| JP2019525744A5 (enExample) | ||
| JP2010512795A5 (enExample) | ||
| JP2019523648A5 (enExample) | ||
| JP2008536483A5 (enExample) | ||
| JP2014529399A5 (enExample) | ||
| JP2017006120A5 (enExample) | ||
| NZ587105A (en) | Tissue protective peptides and peptide analogs for preventing and treating diseases and disorders associated with tissue damage | |
| JP2013172743A5 (enExample) | ||
| JP2015517489A5 (enExample) | ||
| JP2012529293A5 (enExample) | ||
| JP2021536250A5 (enExample) | ||
| JP2010536714A5 (enExample) | ||
| JP2019534884A5 (enExample) | ||
| JP2004533246A5 (enExample) | ||
| Epstein | Targeting memory Th2 cells for the treatment of allergic asthma | |
| JP2015533791A5 (enExample) | ||
| JP2017529326A5 (enExample) | ||
| JP2020073536A5 (enExample) | ||
| JP2017221201A5 (enExample) |